Daan Gene Co., Ltd. (SHE:002030)
China flag China · Delayed Price · Currency is CNY
5.06
-0.01 (-0.20%)
Nov 17, 2026, 3:04 PM CST

Daan Gene Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Cash & Equivalents
813.53506.29872.09999.372,5942,179
Short-Term Investments
-388.19858.761,310485.37-
Trading Asset Securities
380593.896390.08480.9380.01
Cash & Short-Term Investments
1,1941,4881,7942,4003,5612,559
Cash Growth
34.55%-17.03%-25.25%-32.61%39.15%45.53%
Accounts Receivable
599.02819.231,3182,1704,2472,352
Other Receivables
22.7926.3433.625052.7656.46
Receivables
621.81914.081,4612,3534,4452,525
Inventory
143.46147.58198.21239.52369.6493.72
Other Current Assets
1,069293.55328.66318.19393.98407.6
Total Current Assets
3,0282,8443,7825,3108,7695,985
Property, Plant & Equipment
1,4711,5001,7901,9031,767863.06
Long-Term Investments
1,4042,8992,5372,5173,0702,703
Other Intangible Assets
399.66418.39572.72279.7204.12115.03
Long-Term Accounts Receivable
90.6699.8787.4735.9172.0516.62
Long-Term Deferred Tax Assets
344.17344.36358.39228.9199.34112.69
Long-Term Deferred Charges
226.57291.23397.58670.48574.92331.52
Other Long-Term Assets
1,25787.5434.3957.2199.95209.08
Total Assets
8,2508,5119,57711,01814,75710,336

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Accounts Payable
246.82259.68357.87425.44737.07553.01
Accrued Expenses
395.4485.7569.74760.131,559985.63
Short-Term Debt
87.57103.79143.53330.8117.76282.59
Current Portion of Leases
-3.326.9513.2142.6645.32
Current Income Taxes Payable
31.9128.0328.1229.69302383.47
Current Unearned Revenue
43.4735.2966.2334.2369.34152.45
Other Current Liabilities
103.491.57121.3127.58140.9118.58
Total Current Liabilities
908.571,0071,2941,7212,9692,521
Long-Term Leases
1.953.3713.4621.8167.3876.15
Long-Term Unearned Revenue
28.3444.9458.5332.6927.2730.14
Long-Term Deferred Tax Liabilities
60.7763.8861.2479.8547.9746.97
Other Long-Term Liabilities
33.5926.156.935.4129.82.17
Total Liabilities
1,0331,1461,4341,8613,1412,676

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Common Stock
1,4031,4031,4031,4031,4031,403
Additional Paid-In Capital
601.81601.69600.97651.54719.99621.38
Retained Earnings
4,9985,1395,8836,8299,1815,326
Comprehensive Income & Other
-5.89-5.84-7.41-3.92-2.850.5
Total Common Equity
6,9987,1387,8808,88011,3017,351
Minority Interest
218.67226.92263.07276.83314.79308.63
Shareholders' Equity
7,2177,3658,1439,15711,6167,660
Total Liabilities & Equity
8,2508,5119,57711,01814,75710,336

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Total Debt
89.53110.48163.94365.83227.8404.06
Net Cash (Debt)
1,1041,3781,6302,0343,3332,155
Net Cash Growth
41.57%-15.46%-19.86%-38.98%54.66%60.03%
Net Cash Per Share
0.790.981.161.362.371.54
Filing Date Shares Outstanding
1,4031,4031,4031,4031,4031,403
Total Common Shares Outstanding
1,4031,4031,4031,4031,4031,403
Working Capital
2,1201,8362,4883,5895,8003,464
Book Value Per Share
4.995.095.616.338.055.24
Tangible Book Value
6,5986,7197,3078,60111,0977,236
Tangible Book Value Per Share
4.704.795.216.137.915.16
Buildings
-1,139807.22766.64618.81293.09
Machinery
-1,0321,1411,1551,017591.94
Construction In Progress
-311.71776.1727.35576.63210.65